SPHK2 and central nervous system cancer: Ubiquitination of the tumor oncogene sphingosine kinase 2 (SphK2) mediated by NEDD4L overexpression inhibits glioma cell viability and invasion as well as promotes glioma cell apoptosis (Wang et al., 2021).